YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

The Pharmacological Effects of KR-30450 , A Potassium Channel Opener on Coronary Artery Occlusion / Reperfusion-Induced Myocardial Infarction in the Rat

흰쥐에서의 관상동맥 결찰/재관류도 유도된 심근경색에 대한 칼륨통로 개방제 KR-30450의 약리학적 효과

  • 이재흥 (충남대학교 약학대학) ;
  • 권광일 (충남대학교 약학대학) ;
  • 신화섭 (한국화학연구소 의약활성연구실)
  • Published : 1997.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

The pharmacological effects of benzopyran potassium channel openers (lemakalim, KR-30450 and KR-30818) on the occlusion/reperfusion-induced myocardial infarction were investigat ed. In anesthetized rats, subjected to 45-min occlusion of the left anterior descending coronary artery (LAD) followed by 90-min reperfusion, the infarct size was measured by calculating the ratio of infarct zone to area at risk (IZ/AAR) with the Evans blue/TTC technique. Rats were intravenously given vehicle (1% DMSO), lemakalim, KR-30450, and KR-30818 alone or in combination with a selective K$_{ATP}$ blacker glibenclamide, 30 min prior to coronary occlusion. Compared to vehicle, lemakalim (30 ${\mu}$g/kg i.v.), the active enantiomer of cromakalim, had a tendancy to decrease infarct size. KR-30450(30 ${\mu}$g/kg, i.v.). the newly synthetized potassium channel openers (PCOs), caused a reduction of infarct size (from 70${\pm}$4%to 57${\pm}$5%). but KR-30818 (30 ${\mu}$g/kg, i.v.), a metabolite of KR-30450. did not modify infarct size. It seem ed likely that glibenclamide (0.3mg/kg, i.v.), given in combination, reduced the effects of these PCOs, especially KR-30450 (30 ${\mu}$g/kg, i.v.) on the infarct size. These results indicate that. in the coronary occluded rat model of ischemia, lemakalim and KR-30450 may exert cardioprotective activity through a reduction of infarct size, the effect being considered related to the opening of K$_{ATP}$ channel.

Keywords

References

  1. Can. J. Physiol. Pharmacol. Abs. 1994 International Congress of pharmacology (IUPHAR) Meeting, Montreal, Canada
  2. J. Pharmacol. Methods v.23 Improved method for quantification of tissue PMN accumulation measured by myeloperoxdase activity Schierwagen, C.;Bylund-Fellenius, A. C.;Lundberg, C.
  3. Cardiovascular. Drugs and Therapy v.4 The protective effects cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rats hearts and anesthetized dogs Grover, G. J.;Dzwonczyk, S.;Parham, C. S.;Sleph, P.
  4. J. Cardiovasc. Pharmacol. v.16 Pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs Grover, G. J.;Dzwonczy, S.;Parham, C. S.;Sleph, P.
  5. J. Pharmacol. Exp. Ther. v.259 The new $K^+$ channel opener aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes Auchampach, J. A.;Maruyama, M.;Cavero, I.;Gross, G. A.
  6. Life Sci v.47 Cardiovascular and biological effects of $K^+$ channel openers, a class of drugs with vasorelaxants and cardiorotective properties Richer, C.;Pratz, J.;Mulder, P.;Mondot, S.;Giudicelli, J. F.;Cavero, I.
  7. J. Med. Chem. v.33 Relaxant activity of 4-amino-3, 4-dihydro-2H-1-benzopyran-3-ols and 4-amino-2H-1-benzopyrens on guinea pig isolated trachealis Buckle, D. R.;Arch, J. E.;Fenwick, A. E.;Houge-Frydrych, C. S.;Pinto, I. L.
  8. Am. Physiol. Soc. v.260 Effects of cromakalim and lemakalim on slow waves and membrane currents in colonic smooth muscle Post, J. M.;Stevens, R. J.;Sanders, K. A.;Hume, J. R.
  9. J. Cardiovasc. Pharmacol. v.10 Gross, G. J.;Pieper, G. M.;Waltier, D. C.
  10. Angiology v.11 Simple techniques for the surgical occlusion of coronary vessels in the rat Selye, H.;Bajusz, E.;Grasso, S.;Mendell, P.
  11. J. Cardiovasc. Pharmacol. v.23 Protective effects of L-659,989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats Ioculano, M.;Squadrito, F.;Altavilla, D.
  12. J. Pharmacol. Exp. Ther. v.86 Pharmacological evidence for a role of ATP-dependent potassium channela in myocardial stunning Auchampach, J. A.;Maruyama, M.;Cavero, I.;Gross, G.
  13. Eur. J. Phagmacol. v.143 Effects of nicainoprol on reperfusion arrhythmia in the isolated working rat heart and on ischemia and reperfusion arrhythmia and myocardial infarct size in the anesthetized rat Martorana, P. A.;Linz, W.;Gobel, H.;Petry, P.
  14. Am. J. Pathol. v.121 Triphenyltetrazolium staning of irreversible ischemic injury following coronary artery occlusion in rats Vivaldi, M. T.;Kloner, R. A.;Schoen, F. J.
  15. J. Mol. Cell Cardiol. v.23 $K^+$ channel activation with EMD 52692 supresses superoxide anion production by zymosan-activated neutrophils Pieper, G. M.;Gross, G. J.
  16. Eur. J. Pharmacol. v.191 Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891 Grover, G. J.;Dzwonczyk, S.;Sleph, P. G.
  17. J. Moll. Cell Cariol. v.23 ATP-regulated $K^+$ channels protect the myocardium against ischemia-reperfusion damage(Abstract) Cole, W. C.;Mcpherson, C. D.;Sontag, D. P.
  18. Cardiovasc. Res. v.28 Ketamine-xylazine anesthesia permits a $K_{ATP}$ channel antagonist to attenuate preconditioning in rabbit myocardium Walsh, R. S.;Tsuchida, A.;Daly, J. J. F.;Thornton, J. D.;Cohen, M. V.;Downey, J. M.
  19. Folia Pharmacol. Japan v.89 Study of mechanisms and effects of sodium 5-hydroxydecanoate on experimental ischemic ventricular arrhythmia Niho, T.;Notsu, T.;Ishikawa, H.(et. al.)
  20. Cardiovasc. Res. v.28 Potassium channel openers are unlikely to be proarrhythmic in the diseased human heart D'Alonzo, A. J.;Grover, G. J.
  21. Free Radical Bilogy & Medicine v.16 Reduction of myocardial infarct size in rat by IRFI-048, a selective analogue of vitamin E Campo, G.;Squadrito, F.;Altavilla, D.